Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

United Arab Emirates flag United Arab Emirates · Delayed Price · Currency is AED
1.050
-0.030 (-2.78%)
At close: Apr 28, 2026
-26.57%
Market Cap 1.21B
Revenue (ttm) 1.08B
Net Income (ttm) 172.20M
Shares Out 1.16B
EPS (ttm) 0.15
PE Ratio 28.34
Forward PE 11.67
Dividend n/a
Ex-Dividend Date n/a
Volume 791,040
Average Volume 1,658,587
Open 1.080
Previous Close 1.080
Day's Range 1.050 - 1.080
52-Week Range 0.956 - 1.610
Beta -0.21
RSI 49.67
Earnings Date May 11, 2026

About ADX:JULPHAR

Gulf Pharmaceutical Industries P.S.C., together with its subsidiaries, manufactures and sells medicines, drugs, and various other types of pharmaceutical, cosmetic, and medical compounds in United Arab Emirates, other GCC countries, and internationally. It operates through Manufacturing, Planet, Investments, and Others segment. The company offers generic medicines for pain and inflammation, antiviral, respiratory, anti-infectives, immunosuppressants and selective immunosuppressants, cardio care, CNS and psychiatry, vitamins and supplements, wou... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 2,400
Stock Exchange Abu Dhabi Securities Exchange
Ticker Symbol JULPHAR
Full Company Profile

Financial Performance

In 2025, ADX:JULPHAR's revenue was 1.08 billion, an increase of 8.40% compared to the previous year's 992.20 million. Earnings were 172.20 million, an increase of 286.10%.

Financial Statements

News

There is no news available yet.